Sökning: WFRF:(Patel Janki) >
Increased risk of m...
Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease : Systematic Review and Meta-analysis.
-
- Dulai, Parambir S (författare)
- Karolinska Institutet,University of California at San Diego, La Jolla, CA.
-
- Singh, Siddharth (författare)
- University of California at San Diego, La Jolla, CA
-
- Patel, Janki (författare)
- University of California at San Diego, La Jolla, CA
-
visa fler...
-
- Soni, Meera (författare)
- University of California at San Diego, La Jolla, CA
-
- Prokop, Larry J (författare)
- Mayo Clinic, Rochester, Minnesota
-
- Younossi, Zobair (författare)
- Department of Medicine, Inova Fairfax Hospital, Falls Church, VA
-
- Sebastiani, Giada (författare)
- McGill University Health Centre, Montreal, Quebec, Canada
-
- Ekstedt, Mattias, 1976- (författare)
- Linköpings universitet,Medicinska fakulteten,Avdelningen för kardiovaskulär medicin,Region Östergötland, Magtarmmedicinska kliniken
-
- Hagstrom, Hannes (författare)
- Karolinska Institutet,Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
-
- Nasr, Patrik, 1987- (författare)
- Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Magtarmmedicinska kliniken
-
- Stal, Per (författare)
- Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
-
- Wong, Vincent Wai-Sun (författare)
- Chinese University of Hong Kong, Hong Kong
-
- Kechagias, Stergios (författare)
- Linköpings universitet,Medicinska fakulteten,Avdelningen för kardiovaskulär medicin,Region Östergötland, Magtarmmedicinska kliniken
-
- Hultcrantz, Rolf (författare)
- Karolinska Institutet,Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
-
- Loomba, Rohit (författare)
- University of California at San Diego, La Jolla, CA
-
visa färre...
-
Karolinska Institutet University of California at San Diego, La Jolla, CA (creator_code:org_t)
- 2017-03-31
- 2017
- Engelska.
-
Ingår i: Hepatology. - : John Wiley & Sons. - 0270-9139 .- 1527-3350. ; 65:5, s. 1557-1565
- Relaterad länk:
-
https://aasldpubs.on...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Liver fibrosis is the most important predictor of mortality in nonalcoholic fatty liver disease (NAFLD). Quantitative risk of mortality by fibrosis stage has not been systematically evaluated. We aimed to quantify the fibrosis stage-specific risk of all-cause and liver-related mortality in NAFLD.METHODS: Through a systematic review and meta-analysis, we identified 5 adult NAFLD cohort studies reporting fibrosis stage specific mortality (0-4). Using fibrosis stage 0 as a reference population, fibrosis stage-specific mortality rate ratios (MRR) with 95% confidence intervals (CI), for all-cause and liver-related mortality, were estimated. The study is reported according to the PRISMA statement.RESULTS: 1,495 NAFLD patients with 17,452 patient years of follow-up were included. Compared to NAFLD patients with no fibrosis (stage 0), NAFLD patients with fibrosis were at an increased risk for all-cause mortality and this risk increased with increase in the stage of fibrosis: stage 1, MRR, 1.58 (95% CI 1.19-2.11); stage 2, MRR, 2.52 (95% CI 1.85-3.42); stage 3, MRR, 3.48 (95% CI 2.51-4.83), and stage 4, MRR, 6.40 (95% CI 4.11-9.95). The results were more pronounced as the risk of liver-related mortality increased exponentially with increase in the stage of fibrosis: stage 1, MRR, 1.41 (95% CI 0.17-11.95); stage 2, MRR, 9.57 (95% CI 1.67-54.93); stage 3, MRR, 16.69 (95% CI 2.92-95.36); and stage 4, MRR, 42.30 (95% CI 3.51-510.34).LIMITATIONS: Inability to adjust for co-morbid conditions or demographics known to impact fibrosis progression in NAFLD, and the inclusion of patients with simple steatosis and NASH without fibrosis in the reference comparison group.CONCLUSION: The risk of liver-related mortality increases exponentially with increase in fibrosis stage. These data have important implications in assessing utility of each stage and benefits of regression of fibrosis from one stage to another. This article is protected by copyright. All rights reserved.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Gastroenterologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- for (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Dulai, Parambir ...
-
Singh, Siddharth
-
Patel, Janki
-
Soni, Meera
-
Prokop, Larry J
-
Younossi, Zobair
-
visa fler...
-
Sebastiani, Giad ...
-
Ekstedt, Mattias ...
-
Hagstrom, Hannes
-
Nasr, Patrik, 19 ...
-
Stal, Per
-
Wong, Vincent Wa ...
-
Kechagias, Sterg ...
-
Hultcrantz, Rolf
-
Loomba, Rohit
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Gastroenterologi
- Artiklar i publikationen
-
Hepatology
- Av lärosätet
-
Linköpings universitet
-
Karolinska Institutet